Novel small interfering RNA (siRNA) agent lepodisiran drastically cut levels of lipoprotein(a), or Lp(a), in the phase II ...

High blood pressure and cholesterol are two very common health concerns in the UK, but a new study has found that a popular ...

The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.

And according to scientific research, orange juice has the potential to reduce both cholesterol levels and blood pressure. Research, published in the journal Lipids in Health and Disease in 2023, ...

Eli Lilly’s lepodisiran, an investigational siRNA therapy, achieved significant and durable reductions in lipoprotein(a) ...

Eating a small amount of black pepper in your diet every day is perfectly healthy and safe for most people and can be a great ...

Eli Lilly has linked lepodisiran to sustained reductions in a cardiovascular disease risk factor for nearly 1.5 years, ...

Heart disease experts are hailing the results of a clinical trial showed a strongly positive performance by a drug that ...

Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...

Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide ...

Eli Lilly on Sunday said the Phase 2 study of lepodisiran, designed to lower the production of lipoprotein (a), or lp (a), met its primary endpoint, reducing lp (a) levels by an average of 93.9% over ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be ...